KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Capital Leases: 2010-2018

Historic Capital Leases for Charles River Laboratories International (CRL) over the last 7 years, with Dec 2018 value amounting to $29.2 million.

  • Charles River Laboratories International's Capital Leases fell 3.50% to $29.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $29.2 million, marking a year-over-year decrease of 3.50%. This contributed to the annual value of $29.2 million for FY2018, which is 3.50% down from last year.
  • Charles River Laboratories International's Capital Leases amounted to $29.2 million in Q4 2018, which was down 5.06% from $30.8 million recorded in Q3 2018.
  • In the past 5 years, Charles River Laboratories International's Capital Leases registered a high of $37.4 million during Q2 2015, and its lowest value of $717,000 during Q1 2014.
  • For the 3-year period, Charles River Laboratories International's Capital Leases averaged around $30.3 million, with its median value being $30.4 million (2017).
  • Per our database at Business Quant, Charles River Laboratories International's Capital Leases spiked by 3,428.59% in 2015 and then dropped by 19.52% in 2016.
  • Over the past 5 years, Charles River Laboratories International's Capital Leases (Quarterly) stood at $1.0 million in 2014, then surged by 3,260.00% to $33.6 million in 2015, then dropped by 11.01% to $29.9 million in 2016, then climbed by 1.34% to $30.3 million in 2017, then declined by 3.50% to $29.2 million in 2018.
  • Its Capital Leases was $29.2 million in Q4 2018, compared to $30.8 million in Q3 2018 and $30.6 million in Q2 2018.